Literature DB >> 2153707

Insulin resistance is associated with reduced fasting and insulin-stimulated glycogen synthase phosphatase activity in human skeletal muscle.

Y Kida1, A Esposito-Del Puente, C Bogardus, D M Mott.   

Abstract

Insulin-stimulated glycogen synthase activity in human skeletal muscle correlates with insulin-mediated glucose disposal rate (M) and is reduced in insulin-resistant subjects. We have previously reported reduced insulin-stimulated glycogen synthase activity associated with reduced fasting glycogen synthase phosphatase activity in skeletal muscle of insulin-resistant Pima Indians. In this study we investigated the time course for insulin stimulation of glycogen synthase and synthase phosphatase during a 2-h high-dose insulin infusion (600 mU/min per m2) in six insulin-sensitive caucasians (group S) and in five insulin-resistant Pima Indians (group R). Percutaneous muscle biopsies were obtained from the quadriceps femoris muscle after insulin infusion for 0, 10, 20, 40, and 120 min. In group S, insulin-stimulated glycogen synthase activity increased with time and was significantly higher than in group R. In group S, synthase phosphatase activity increased significantly by 25% at 10 min and then decreased gradually. No significant change in synthase phosphatase was seen in group R and activity was lower than group S at 0 to 20 min. These data suggest that a low basal synthase phosphatase activity and a defect in its response to insulin explain, at least in part, reduced insulin stimulation of skeletal muscle glycogen synthase associated with insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153707      PMCID: PMC296448          DOI: 10.1172/JCI114462

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  GLYCOGEN SYNTHETASE ACTIVITY IN SKELETAL MUSCLE. INTERCONVERSION OF TWO FORMS AND CONTROL OF GLYCOGEN SYNTHESIS.

Authors:  W H DANFORTH
Journal:  J Biol Chem       Date:  1965-02       Impact factor: 5.157

2.  Stimulation of protein phosphatase activity by insulin and growth factors in 3T3 cells.

Authors:  C P Chan; S J McNall; E G Krebs; E H Fischer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

3.  Acute regulation of hepatic protein phosphatases by glucagon, insulin, and glucose.

Authors:  B Tóth; M Bollen; W Stalmans
Journal:  J Biol Chem       Date:  1988-10-05       Impact factor: 5.157

4.  The role of ATP and glucose 6-phosphate in the regulation of glycogen synthetase D phosphatase.

Authors:  D P Gilboe; F Q Nuttall
Journal:  Biochem Biophys Res Commun       Date:  1972-08-21       Impact factor: 3.575

5.  A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose.

Authors:  J A Thomas; K K Schlender; J Larner
Journal:  Anal Biochem       Date:  1968-10-24       Impact factor: 3.365

6.  Long term regulation of glycogen metabolizing enzymes by insulin in H4 hepatoma cells.

Authors:  M A Goheer; J Larner; R T Curnow
Journal:  Mol Cell Biochem       Date:  1987-06       Impact factor: 3.396

7.  Glucose-6-phosphate stimulation of human muscle glycogen synthase phosphatase.

Authors:  M Okubo; C Bogardus; S Lillioja; D M Mott
Journal:  Metabolism       Date:  1988-12       Impact factor: 8.694

8.  Impaired insulin-stimulated muscle glycogen synthase activation in vivo in man is related to low fasting glycogen synthase phosphatase activity.

Authors:  D Freymond; C Bogardus; M Okubo; K Stone; D Mott
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

9.  Muscle glycogen synthesis and disposition of infused glucose in humans with reduced rates of insulin-mediated carbohydrate storage.

Authors:  A A Young; C Bogardus; D Wolfe-Lopez; D M Mott
Journal:  Diabetes       Date:  1988-03       Impact factor: 9.461

10.  Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism.

Authors:  L J Mandarino; K S Wright; L S Verity; J Nichols; J M Bell; O G Kolterman; H Beck-Nielsen
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

View more
  34 in total

1.  A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM.

Authors:  G Paolisso; P A Tataranni; J E Foley; C Bogardus; B V Howard; E Ravussin
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

Review 2.  Alterations of glucose metabolism in type 2 diabetes mellitus. An overview.

Authors:  Riccardo C Bonadonna
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

3.  Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylurea-induced improvement of glycaemic control.

Authors:  H Vestergaard; S Lund; C Bjørbaek; O Pedersen
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

Review 4.  Adipocyte, adipose tissue, and infectious disease.

Authors:  Mahalia S Desruisseaux; Maria E Trujillo; Herbert B Tanowitz; Philipp E Scherer
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

5.  Impaired skeletal muscle glycogen synthase activation by insulin in the Goto-Kakizaki (G/K) rat.

Authors:  C Villar-Palasi; R V Farese
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

Review 6.  Nutritional and endocrine modulation of intracellular calcium: implications in obesity, insulin resistance and hypertension.

Authors:  M B Zemel
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

7.  Defective insulin response of cyclic adenosine monophosphate-dependent protein kinase in insulin-resistant humans.

Authors:  Y Kida; B L Nyomba; C Bogardus; D M Mott
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

8.  Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus.

Authors:  A Vaag; J E Henriksen; H Beck-Nielsen
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

Review 9.  Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  J P Felber; E Haesler; E Jéquier
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

10.  Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes.

Authors:  R C Bonadonna; S Del Prato; M P Saccomani; E Bonora; G Gulli; E Ferrannini; D Bier; C Cobelli; R A DeFronzo
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.